Patterns of substance use among HIV-positive adults over 50: Implications for treatment and medication adherence

Drug and Alcohol Dependence

Volumn 139, Issue , 2014, Pages 33-40

  Parsons, Jeffrey T ^a,b,c,d   Starks, Tyrel J ^a,e   Millar, Brett M ^b,c   Boonrai, Kailip ^a   Marcotte, David ^f  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Center for HIV AIDS Educational Studies and Training   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

^e PACE UNIVERSITY   (United States)

^f FORDHAM UNIVERSITY   (United States)

Author keywords

HIV and aging; Medication adherence; Older adults; Substance use

Indexed keywords

ALCOHOL; AMYL NITRITE; ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; OPIATE;

10 ITEM DRUG ABUSE SCREENING TEST; ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ALCOHOL USE DISORDERS IDENTIFICATION TEST CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; BISEXUAL FEMALE; BISEXUAL MALE; CANNABIS ADDICTION; CLINICAL ASSESSMENT TOOL; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ABUSE PATTERN; FEMALE; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; SUBSTANCE ABUSE; ALCOHOLISM; COCAINE-RELATED DISORDERS; HIV SEROPOSITIVITY; MARIJUANA ABUSE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

CANNABIS SATIVA;

ALCOHOLISM; COCAINE-RELATED DISORDERS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MARIJUANA ABUSE; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 84899898653     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.02.704     Document Type: Article

References (58)

1. Akaike H. Information theory and an extension of the maximum likelihood principle. Second International Symposium in Information Theory 1973, 267-281. Akademiai, Kiado, Budapest. B.N. Petrov, F. Csaki (Eds.).
2. Arnsten J.H., Demas P.A., Grant R.W., Gourevitch M.N., Farzadegan H., Howard A.A., Schoenbaum E.E. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J. Gen. Intern. Med. 2002, 17:377-381.
3. Asparouhov T., Muthèn B.O. Auxiliary variables in mixture modeling: 3-step approaches using Mplus. Mplus Web Notes, 15 version 5 2012, 1-39. retrieved 01.06.13, from http://www.statmodel.com/examples/webnotes/webnote15.pdf.
4. Balderson B.H., Grothaus L., Harrison R.G., McCoy K., Mahoney C., Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care 2013, 25:451-458.
5. Bangsberg D.R., Perry S., Charlebois E.D., Clark R.A., Roberston M., Zolopa A.R., Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001, 15:1181-1183.
6. Barclay T.R., Hinkin C.H., Castellon S.A., Mason K.I., Reinhard M.J., Marion S.D., Levine A.J., Durvasula R.S. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007, 26:40-49.
7. Baum M.K., Rafie C., Lai S., Sales S., Page B., Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J. Acquir. Immune Defic. Syndr. 2009, 50:93-99.
8. Blouin A.G., Perez E.L., Blouin J.H. Computerized administration of the diagnostic interview schedule. Psychiatry Res. 1988, 23:335-344.
9. Briggs W.P., Magnus V.A., Lassiter P., Patterson A., Smith L. Substance use, misuse, and abuse among older adults: implications for clinical mental health counselors. JMHC 2011, 33:112-127.
10. Burney K.D., Krishnan K., Ruffin M.T., Zhang D., Brenner D.E. Adherence to single daily dose of aspirin in a chemoprevention trial: an evaluation of self-report and microelectronic monitoring. Arch. Fam. Med. 1996, 5:297-300.
11. Bush K., Kivlahan D.R., McDonell M.B., Fihn S.D., Bradley K.A. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch. Intern. Med. 1998, 158:1789-1795.
12. Catz S.L., Heckman T.G., Kochman A., DiMarco M. Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease. Psychol. Health. Med. 2001, 6:47-58.
13. Centers for Disease Control and Prevention Diagnoses of HIV infection among adults aged 50 years and older in the United States and dependent areas, 2007-2010. HIV Surveillance Supplemental Report 2013 2013, 18. retrieved 01.07.13, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental.
14. Cohn S.E., Jiang H., McCutchan J.A., Koletar S.L., Murphy R.L., Robertson K.R., de St., Maurice A.M., Currier J.S., Williams P.L. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care 2011, 23:775-785.
15. Cooperman N.A., Arnsten J.H., Klein R.S. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ. Prev. 2007, 19:321-333.
16. Emlet C.A. "You're awfully old to have this disease": experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist 2006, 46:781-790.
17. Golub S.A., Tomassilli J.C., Pantalone D.W., Brennan M., Karpiak S.E., Parsons J.T. Prevalence and correlates of sexual behavior and risk management among HIV-positive adults over 50. Sex. Transm. Dis. 2010, 37:615-620.
18. Gonzalez A., Barinas J., O'Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr. HIV/AIDS Rep. 2011, 8:223-234.
19. Gonzalez A., Mimiaga M.J., Israel J., Bedoya C.A., Safren S.A. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment. AIDS Behav. 2013, 17:168-173.
20. Green T.C., Kershaw T., Lin H., Heimer R., Goulet J.L., Kraemer K.L., Gordon A.J., Maisto S.A., Day N.L., Bryant K., Fiellin D.A., Justice A.C. Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort. Drug Alcohol Depend. 2010, 110:208-220.
21. Greene M., Justice A.C., Lampiris H.W., Valcour V. Management of Human Immunodeficiency Virus infection in advanced age. JAMA 2013, 309:1397-1405.
22. Grov C., Golub S.A., Parsons J.T., Brennan M., Karpiak S.E. Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care 2010, 22:630-639.
23. Han B., Gfroerer J., Colliver J. An Examination of Trends in Illicit Drug Use Among Adults Aged 50 to 59 in the United States. Office of Applied Studies, Substance Abuse and Mental Health Service Administration 2009, retrieved 01.07.13, from http://www.samhsa.gov/data/2k11/DataReview/OAS_data_review_OlderAdults.pdf.
24. Hardy D.J., Vance D.E. The neuropsychology of HIV/AIDS in older adults. Neuropsychol. Rev. 2009, 19:263-272.
25. Harrison L.D., Martin S.S., Enev T., Harrington D. Comparing Drug Testing and Self-report of Drug Use Among Youths and Young Adults in the General Population 2007, Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
26. Havlik R.J., Brennan M., Karpiak S.E. Comorbidities and depression in older adults with HIV. Sex. Health 2011, 8:551-559.
27. Heckman T.G., Heckman B.D., Kochman A., Sikkema K.J., Suhr J.A., Goodkin K. Psychological symptoms among persons 50 years of age and older living with HIV disease. Aging Ment. Health. 2002, 6:121-128.
28. Hinkin C.H., Castellon S.A., Atkinson J.H., Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J. Clin. Epidemiol. 2001, 54:S44-S52.
29. Hinkin C.H., Barclay T.R., Castellon S.A., Levine A.J., Durvasula R.S., Marion S.D., Myers H.F., Longshore D. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007, 11:185-194.
30. Ingersoll K.S., Farrell-Carnahan L., Cohen-Filipic J., Heckman C.J., Ceperich S.D., Hettema J., Marzani-Nissen G. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug Alcohol Depend. 2011, 116:177-187.
31. Johnson C.J., Heckman T.G., Hansen N.B., Kochman A., Sikkema K.J. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care 2009, 21:541-551.
32. Jung T., Wickrama K.A. An introduction to latent class growth analysis and growth mixture modeling. Soc. Personal. Psychol. Compass. 2008, 2:302-317.
33. Justice A.C. HIV and aging: time for a new paradigm. Curr. HIV/AIDS Rep. 2010, 7:69-76.
34. Kedia S., Sell M.A., Relyea G. Mono- versus polydrug abuse patterns among publicly funded clients. Subst. Abuse Treat. Prev. Policy 2007, 2:1-9.
35. Kerr T., Palepu A., Barnes G., Walsh J., Hogg R.S., Montaner J., Tyndall M., Wood E. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir. Ther. 2004, 9:407-414.
36. Leri F., Bruneau J., Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003, 98:7-22.
37. Liu H., Golin C.E., Miller L.G., Hays R.D., Beck C.K., Sanandaji S., Christian J., Maldonado T., Duran D., Kaplan A.H., Wenger N.S. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann. Intern. Med. 2001, 134:968-977.
38. Lovejoy T.I., Heckman T.G., Sikkema K.J., Hansen N.B., Kochman A., Suhr J.A., Garske J.P., Johnson C.J. Patterns and correlates of sexual activity and condom use behavior in persons 50-plus years of age living with HIV/AIDS. AIDS Behav. 2008, 12:943-956.
39. Malta M., Strathdee S.A., Magnanini M.M., Bastos F.I. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008, 103:1242-1257.
40. Midanik L.T., Tam T.W., Weisner C. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007, 90:72-80.
41. Monga N., Rehm J., Fischer B., Brissette S., Bruneau J., El-Guebaly N., Noel L., Tyndall M., Wild C., Leri F., Fallu J.S., Bahl S. Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend. 2007, 88:1-8.
42. Muthèn B.O., Muthèn L.K. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcohol. Clin. Exp. Res. 2000, 24:882-891.
43. Nylund K.L., Asparouhov T., Muthèn B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct. Eq. Model. 2007, 14:535-569.
44. Oursler K.K., Goulet J.L., Leaf D.A., Akingicil A., Katzel L.I., Justice A., Crystal S. Association of comorbidity with physical disability in older HIV-infected adults. Aids Patient Care STDS 2006, 20:782-791.
45. Parsons J.T., Kowalczyk W.J., Botsko M., Tomassilli J.C., Golub S.A. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav. 2013, 17:1478-1487.
46. Paterson D.L., Swindells S., Mohr J., Brester M., Vergis E.N., Squier C., Wagener M.M., Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med. 2000, 133:21-30.
47. Rabkin J.G., McElhiney M.C., Ferrando S.J. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS 2004, 18:S43-S48.
48. Raferty A. Bayesian model selection in social research (with discussion). Sociological Methodology 1995, 111-196. Blackwells, Cambridge, MA. P. Marsden (Ed.).
49. Ramaswamy V., DeSarbo W.S., Reibstein D.J., Robinson W. The empirical pooling approach for estimating marketing mix elasticities with PIMS data. J. Acad. Market. Sci. 1993, 12:103-124.
50. Reback C.J., Larkins S., Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003, 15:775-785.
51. Rodriguez-Penney A.T., Iudicello J.E., Riggs P.K., Doyle K., Ellis R.J., Letendre S.L., Grant I., Woods S.P. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. Aids Patient Care STDS 2013, 27:5-16. HIV Neurobehavioral Research Group.
52. Shi L., Liu J., Koleva Y., Fonseca V., Kalsekar A., Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010, 28:1097-1107.
53. Shippy R.A., Karpiak S.E. Perceptions of support among older adults with HIV. Res. Aging 2005, 27:290-306.
54. Simoni J.M., Kurth A.E., Pearson C.R., Pantalone D.W., Merrill J.O., Frick P.A. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006, 10:227-245.
55. Skalski L.M., Sikkema K.J., Heckman T.G., Meade C.S. Coping styles and illicit drug use in older adults with HIV/AIDS. Psychol. Addict. Behav. 2013, 10.1037/a0031044.
56. Skinner H.A. The drug abuse screening test. Addict. Behav. 1982, 7:363-371.
57. Sorocco K.H., Ferrell S.W. Alcohol use among older adults. J. Gen. Psychol. 2006, 133:453-467.
58. Wagner G.J., Rabkin J.G. Measuring medication adherence: are missed doses reported more accurately than perfect adherence?. AIDS Care 2000, 12:405-408.